OR WAIT null SECS
September 29, 2015
The CDMO is striving to become a market leader in the development and manufacturing of antibody-drug conjugates.
September 25, 2015
There is growing interest in the development of liquid formulations in prefilled syringes and autoinjectors, which offer convenience and ease of administration in a home setting.
September 24, 2015
Cobra Biologics and the University of Manchester announce a collaboration to improve industrial scale-up of mammalian cell bioprocessing.
September 22, 2015
In testifying before Congress on FDA regulation of long-awaited biosimilars, Janet Woodcock emphasized the importance of ensuring that the evaluation of new therapies is based on sound science.
September 16, 2015
Nexvet Biopharma, a veterinary biologics developer, secured a dedicated, cGMP biologics manufacturing facility in Tullamore, Ireland, and plans to invest in disposable technology.
September 15, 2015
Manufacturers challenge details in new policies designed to promote access to important therapies.
September 09, 2015
Aragen Bioscience has licensed ProteoNic Biotechnology’s 2G UNic recombinant protein production technology, which increases manufacturing efficiency and reduces cost of goods for recombinant biologicals.
September 03, 2015
After many legal proceedings surrounding the first FDA-approved biosimilar, Zarxio officially launched commercially on Sept. 3, 2015.
September 02, 2015
Creating closed processes and reducing room air classification in a biopharmaceutical facility can reduce operational costs.
Industry Expert Q&A with Robin M. Silva, Partner, Morgan, Lewis, and Bockius LLP